Biological
MVA.tHIVconsv4 clinical trials
- studies test it
- 4
- open now
- 2
- in phase 3
- 0
- first study started
- 2019
Keep track of what changes. Save the MVA.tHIVconsv4 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
4 studies that test it; most in 2025 (2)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2022 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 4
University of North Carolina, Chapel Hill (2) · Henry M. Jackson Foundation for the Advancement of Military Medicine (1) · University of Oxford (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses MVA.tHIVconsv4 is read from its arms, and is right about nine times in ten.
Testing it · 4
- RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEVRecruitingPhase 1Henry M. Jackson Foundation for the Advancement of Military MedicineNCT06484335Written as MVA.tHIVconsv4
- Combination Vaccination and Broadly Neutralising Antibody Therapy in HIVRecruitingPhase 2University of OxfordNCT07054931Written as MVA.tHIVconsv4
- Study to Assess Safety and Ability to Induce Immune Responses of HIV-1 Vaccines M3 and M4 Given Alone or in Combination in HIV-infected AdultsCompletedPhase 1University of North Carolina, Chapel HillNCT03844386Written as MVA.tHIVconsv4
- Safety and Immunogenicity of HIV-1 Vaccines C62-M4 or C1C62-M3M4 in Persons With HIV-1 Suppressed on ARTCompletedPhase 1University of North Carolina, Chapel HillNCT05604209Written as MVA.tHIVconsv4